{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:44:32Z","timestamp":1789026272837,"version":"build-2803163510"},"reference-count":413,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Frontiers in Neuroendocrinology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.yfrne.2024.101122","type":"journal-article","created":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T00:07:24Z","timestamp":1707610044000},"page":"101122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer\u2019s and Parkinson\u2019s disease"],"prefix":"10.1016","volume":"73","author":[{"given":"Niklas","family":"Reich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0005","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0306-3623(98)00075-5","article-title":"Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety","volume":"31","author":"Acosta","year":"1998","journal-title":"Gen Pharmacol"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1532-0456(00)00175-7","article-title":"A possible interaction between CCKergic and GABAergic systems in the rat brain","volume":"128","author":"Acosta","year":"2001","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b0015","doi-asserted-by":"crossref","first-page":"e45179","DOI":"10.1371\/journal.pone.0045179","article-title":"Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model","volume":"7","author":"Adebakin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yfrne.2024.101122_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.peptides.2015.07.010","article-title":"Nonsulfated cholecystokinins in the small intestine of pigs and rats","volume":"71","author":"Agersnap","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.yfrne.2024.101122_b0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.npep.2016.08.003","article-title":"Nonsulfated cholecystokinins in cerebral neurons","volume":"60","author":"Agersnap","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yfrne.2024.101122_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101905","article-title":"BDNF and Netrin-1 repression by C\/EBPbeta in the gut triggers Parkinson's disease pathologies, associated with constipation and motor dysfunctions","volume":"198","author":"Ahn","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(91)90149-P","article-title":"Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity","volume":"557","author":"Akaike","year":"1991","journal-title":"Brain Res."},{"issue":"2\u20133","key":"10.1016\/j.yfrne.2024.101122_b0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","article-title":"The Vulnerable Ventral Tegmental Area in Parkinson's Disease","volume":"5","author":"Alberico","year":"2015","journal-title":"Basal Ganglia"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(89)90176-5","article-title":"Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin","volume":"483","author":"Altar","year":"1989","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-9158-3-25","article-title":"Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders","volume":"3","author":"Anderson","year":"2014","journal-title":"Transl Neurodegener"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0055","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1113\/jphysiol.2011.223669","article-title":"Basket cell dichotomy in microcircuit function","volume":"590","author":"Armstrong","year":"2012","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuron.2020.07.039","article-title":"Neuropeptides Modulate Local Astrocytes to Regulate Adult Hippocampal Neural Stem Cells","volume":"108","author":"Asrican","year":"2020","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040778","article-title":"Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease: Review and Meta-Analysis","volume":"10","author":"Athanasaki","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0070","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/mds.29122","article-title":"The Impact of Type 2 Diabetes in Parkinson's Disease","volume":"37","author":"Athauda","year":"2022","journal-title":"Mov Disord"},{"issue":"20","key":"10.1016\/j.yfrne.2024.101122_b0075","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1523\/JNEUROSCI.2385-16.2017","article-title":"Inhibition of Drp1 Ameliorates Synaptic Depression, Abeta Deposition, and Cognitive Impairment in an Alzheimer's Disease Model","volume":"37","author":"Baek","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yfrne.2024.101122_b0080","doi-asserted-by":"crossref","first-page":"4050796","DOI":"10.1155\/2019\/4050796","article-title":"The Role of Mitochondrial Damage-Associated Molecular Patterns in Chronic Neuroinflammation","volume":"2019","author":"Bajwa","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1515\/revneuro-2016-0088","article-title":"The unappreciated roles of the cholecystokinin receptor CCK(1) in brain functioning","volume":"28","author":"Ballaz","year":"2017","journal-title":"Rev Neurosci"},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b0090","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2174\/1570159X18666201113145143","article-title":"Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A \u201cDimmer-Switch\u201d Hypothesis","volume":"19","author":"Ballaz","year":"2021","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/jbcpp-2021-0182","article-title":"Emphasizing roles of BDNF promoters and inducers in Alzheimer's disease for improving impaired cognition and memory","volume":"34","author":"Banerjee","year":"2023","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0100","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1210\/en.2005-0419","article-title":"Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex","volume":"146","author":"Bariohay","year":"2005","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0105","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina","year":"2015","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41531-022-00321-y","article-title":"Mechanisms of peripheral levodopa resistance in Parkinson's disease","volume":"8","author":"Beckers","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b0120","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hipo.22141","article-title":"Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity","volume":"23","author":"Bezaire","year":"2013","journal-title":"Hippocampus"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0130","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1152\/ajpregu.00002.2007","article-title":"Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors","volume":"293","author":"Bi","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"16","key":"10.1016\/j.yfrne.2024.101122_b0135","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1128\/MCB.00337-12","article-title":"Defective mitochondrial morphology and bioenergetic function in mice lacking the transcription factor Yin Yang 1 in skeletal muscle","volume":"32","author":"Blattler","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0143-4179(88)90037-6","article-title":"Effects of cholecystokinin and pentagastrin on rat hippocampal neurones maintained in vitro","volume":"12","author":"Boden","year":"1988","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0145","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"20","key":"10.1016\/j.yfrne.2024.101122_b0150","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1113\/JP271539","article-title":"Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation","volume":"594","author":"Bonaz","year":"2016","journal-title":"J Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.yfrne.2024.101122_b0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"issue":"1\u20133","key":"10.1016\/j.yfrne.2024.101122_b0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0167-0115(03)00194-0","article-title":"Anti-inflammatory effects of leptin and cholecystokinin on acetic acid-induced colitis in rats: role of capsaicin-sensitive vagal afferent fibers","volume":"116","author":"Bozkurt","year":"2003","journal-title":"Regul Pept"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0165","first-page":"178","article-title":"Neurobiological investigations into the role of cholecystokinin in panic disorder","volume":"18","author":"Bradwejn","year":"1993","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/070674379003500115","article-title":"Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder","volume":"35","author":"Bradwejn","year":"1990","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0175","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1994.03950060050005","article-title":"The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder","volume":"51","author":"Bradwejn","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b0180","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/ajp.154.5.700","article-title":"Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder","volume":"154","author":"Brawman-Mintzer","year":"1997","journal-title":"Am J Psychiatry"},{"issue":"24","key":"10.1016\/j.yfrne.2024.101122_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(97)00678-2","article-title":"Cholecystokinin (CCK-8) modulates vesicular release of excitatory amino acids in rat hippocampal nerve endings","volume":"234","author":"Breukel","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"Jul","key":"10.1016\/j.yfrne.2024.101122_b0195","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1749-6632.1985.tb29931.x","article-title":"Cholecystokinin as a Potent Excitant of Neurons of the Dentate Gyrus of Rats","volume":"448","author":"Brooks","year":"1985","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0306-4522(01)00474-2","article-title":"Expression of the leptin receptor in rat and human nodose ganglion neurones","volume":"109","author":"Burdyga","year":"2002","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002130051176","article-title":"Self-administration of intravenous amphetamine: effect of nucleus accumbens CCKB receptor activation on fixed-ratio responding","volume":"147","author":"Bush","year":"1999","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.0953-816x.2001.01628.x","article-title":"Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve","volume":"14","author":"Buyse","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.yfrne.2024.101122_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4951379","article-title":"Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review","volume":"2019","author":"Camargo Maluf","year":"2019","journal-title":"Parkinsons Disease"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0220","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1113\/jphysiol.2014.286740","article-title":"The role of alterations in mitochondrial dynamics and PGC-1alpha over-expression in fast muscle atrophy following hindlimb unloading","volume":"593","author":"Cannavino","year":"2015","journal-title":"J Physiol"},{"issue":"31","key":"10.1016\/j.yfrne.2024.101122_b0225","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2222095120","article-title":"Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus","volume":"120","author":"Caramia","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yfrne.2024.101122_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170492","article-title":"The critical role of CCK in the regulation of food intake and diet-induced obesity","volume":"138","author":"Cawthon","year":"2021","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-021-00456-1","article-title":"Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns","volume":"16","author":"Chen","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.yfrne.2024.101122_b0240","first-page":"1","article-title":"Meta-analysis: overweight, obesity, and Parkinson's disease","volume":"2014","author":"Chen","year":"2014","journal-title":"Int. J. Endocrinol."},{"issue":"13","key":"10.1016\/j.yfrne.2024.101122_b0245","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1073\/pnas.1816833116","article-title":"Cholecystokinin release triggered by NMDA receptors produces LTP and sound-sound associative memory","volume":"116","author":"Chen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1756285613495723","article-title":"Anxiety in Parkinson's disease: identification and management","volume":"7","author":"Chen","year":"2014","journal-title":"Ther Adv Neurol Disord"},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b0255","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.0505407103","article-title":"Elevated cholecystokininergic tone constitutes an important molecular\/neuronal mechanism for the expression of anxiety in the mouse","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0260","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2003.11.012","article-title":"Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice","volume":"126","author":"Chen","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0265","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"issue":"5923","key":"10.1016\/j.yfrne.2024.101122_b0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1171091","article-title":"S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury","volume":"324","author":"Cho","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0275","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s13311-021-01067-w","article-title":"Nutritional Ketosis in Parkinson's Disease - a Review of Remaining Questions and Insights","volume":"18","author":"Choi","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0280","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1471-4159.2008.05399.x","article-title":"A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells","volume":"106","author":"Choi","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yfrne.2024.101122_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/370526","article-title":"MMP-3 contributes to nigrostriatal dopaminergic neuronal loss, BBB damage, and neuroinflammation in an MPTP mouse model of Parkinson's disease","volume":"2013","author":"Chung","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0290","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/en.2006-1064","article-title":"Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice","volume":"148","author":"Clerc","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0306-4522(01)00440-7","article-title":"Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus","volume":"109","author":"Cope","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.yfrne.2024.101122_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1985.tb29900.x","article-title":"Comparative distribution of cholecystokinin and other neuropeptides. Why is this peptide different from all other peptides?","volume":"448","author":"Crawley","year":"1985","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0305","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1523\/JNEUROSCI.05-08-01972.1985","article-title":"Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence","volume":"5","author":"Crawley","year":"1985","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0310","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/jpet.114.215293","article-title":"The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases beta-cell mass without affecting islet number in db\/db mice","volume":"350","author":"Dalboge","year":"2014","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0143-4179(98)90041-5","article-title":"Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide","volume":"32","author":"De la Fuente","year":"1998","journal-title":"Neuropeptides"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0320","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","article-title":"Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers","volume":"46","author":"de Montigny","year":"1989","journal-title":"Preliminary findings. Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0325","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nn.4544","article-title":"Abnormal wiring of CCK(+) basket cells disrupts spatial information coding","volume":"20","author":"Del Pino","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0330","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02247385","article-title":"Pentagastrin has panic inducing properties in obsessive compulsive disorder","volume":"126","author":"deLeeuw","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0335","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0091-3057(02)00823-7","article-title":"Dose-response relationships of intranasal cholecystokinin and the P300 event-related brain potential","volume":"73","author":"Denecke","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0031-9384(04)00347-6","article-title":"Repetitive intranasal administration of cholecystokinin potentiates its central nervous effects","volume":"83","author":"Denecke","year":"2004","journal-title":"Physiol Behav"},{"issue":"Pt 2","key":"10.1016\/j.yfrne.2024.101122_b0345","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1113\/jphysiol.2005.104463","article-title":"Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats","volume":"572","author":"Deng","year":"2006","journal-title":"J Physiol"},{"issue":"15","key":"10.1016\/j.yfrne.2024.101122_b0350","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1523\/JNEUROSCI.5711-09.2010","article-title":"Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability","volume":"30","author":"Deng","year":"2010","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0091-3057(98)00107-5","article-title":"The expression of behavioral sensitization to amphetamine: role of CCK(A) receptors","volume":"62","author":"DeSousa","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0360","doi-asserted-by":"crossref","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson's disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1\u20133","key":"10.1016\/j.yfrne.2024.101122_b0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0169-328X(92)90070-R","article-title":"Dopaminergic regulation of cholecystokinin mRNA content in rat striatum","volume":"12","author":"Ding","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41421-022-00420-3","article-title":"Structural insights into human brain-gut peptide cholecystokinin receptors","volume":"8","author":"Ding","year":"2022","journal-title":"Cell Discov"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0375","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(81)90344-9","article-title":"The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus","volume":"205","author":"Dodd","year":"1981","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b0380","first-page":"331","article-title":"Acute effect of cholecystokinin on short-term synaptic plasticity in the rat hippocampus","volume":"9","author":"Dolatabadi","year":"2014","journal-title":"Res Pharm Sci"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0385","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuron.2015.01.011","article-title":"Early- and late-born parvalbumin basket cell subpopulations exhibiting distinct regulation and roles in learning","volume":"85","author":"Donato","year":"2015","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0390","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0395","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.neuron.2021.01.003","article-title":"Alternating sources of perisomatic inhibition during behavior","volume":"109","author":"Dudok","year":"2021","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0400","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(95)00737-7","article-title":"Molecular cloning, developmental expression and pharmacological characterization of the CCKB\/gastrin receptor in the calf pancreas","volume":"297","author":"Dufresne","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0405","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00014.2005","article-title":"Cholecystokinin and gastrin receptors","volume":"86","author":"Dufresne","year":"2006","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b0410","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.neurobiolaging.2013.11.001","article-title":"Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease","volume":"35","author":"Dunn","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"23","key":"10.1016\/j.yfrne.2024.101122_b0415","doi-asserted-by":"crossref","first-page":"13632","DOI":"10.1073\/pnas.2234031100","article-title":"Inflammation is detrimental for neurogenesis in adult brain","volume":"100","author":"Ekdahl","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0420","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1084\/jem.20021546","article-title":"CD36 mediates the innate host response to beta-amyloid","volume":"197","author":"El Khoury","year":"2003","journal-title":"J Exp Med"},{"issue":"22","key":"10.1016\/j.yfrne.2024.101122_b0425","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1016\/j.bmcl.2010.08.115","article-title":"Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]tri azolo[4,3-a][1,5 benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity","volume":"20","author":"Elliott","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0430","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-007-0738-7","article-title":"Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study","volume":"192","author":"Eser","year":"2007","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0435","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hbm.20522","article-title":"Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers","volume":"30","author":"Eser","year":"2009","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0440","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(03)00767-5","article-title":"Altered extracellular dopamine concentration in the brains of cholecystokinin-A receptor deficient rats","volume":"348","author":"Feifel","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.yfrne.2024.101122_b0445","doi-asserted-by":"crossref","unstructured":"Feng, H., Su, J., Fang, W., Chen, X., & He, J. (2021). The entorhinal cortex modulates trace fear memory formation and neuroplasticity in the mouse lateral amygdala via cholecystokinin. Elife, 10. doi:10.7554\/eLife.69333.","DOI":"10.7554\/eLife.69333"},{"key":"10.1016\/j.yfrne.2024.101122_b0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neuropharm.2018.02.012","article-title":"Two novel dual GLP-1\/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease","volume":"133","author":"Feng","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yfrne.2024.101122_b0455","doi-asserted-by":"crossref","first-page":"32656","DOI":"10.1038\/srep32656","article-title":"Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP","volume":"6","author":"Filichia","year":"2016","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b0460","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nn1952","article-title":"Cell type-specific gating of perisomatic inhibition by cholecystokinin","volume":"10","author":"Foldy","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0465","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1463-1326.2012.01676.x","article-title":"The novel GLP-1-gastrin dual agonist, ZP3022, increases beta-cell mass and prevents diabetes in db\/db mice","volume":"15","author":"Fosgerau","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2007.09.012","article-title":"Perisomatic inhibition","volume":"56","author":"Freund","year":"2007","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0475","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0303-7207(99)00061-1","article-title":"Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction","volume":"151","author":"Frodin","year":"1999","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b0480","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1034\/j.1399-0004.1999.560508.x","article-title":"Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease","volume":"56","author":"Fujii","year":"1999","journal-title":"Clin. Genet."},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0485","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.yfrne.2024.101122_b0490","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fncel.2017.00184","article-title":"Activation of the CREB\/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer","volume":"11","author":"Gandolfi","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0495","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-1781(98)00063-8","article-title":"An association of NAG levels and a mutation of the CCK gene in panic disorder patients","volume":"80","author":"Garvey","year":"1998","journal-title":"Psychiatry Res"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0500","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0196-9781(01)00449-1","article-title":"Estradiol, CCK and satiation","volume":"22","author":"Geary","year":"2001","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0505","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-8993(96)00099-6","article-title":"The increased satiating potency of CCK-8 by estradiol is not mediated by upregulation of NTS CCK receptors","volume":"719","author":"Geary","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.yfrne.2024.101122_b0510","doi-asserted-by":"crossref","first-page":"1002960","DOI":"10.3389\/fnsyn.2022.1002960","article-title":"Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective","volume":"14","author":"Gerfen","year":"2022","journal-title":"Front Synaptic Neurosci"},{"issue":"4986","key":"10.1016\/j.yfrne.2024.101122_b0515","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0520","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1037\/h0034870","article-title":"Cholecystokinin decreases food intake in rats","volume":"84","author":"Gibbs","year":"1973","journal-title":"J Comp Physiol Psychol"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0525","doi-asserted-by":"crossref","first-page":"e1008352","DOI":"10.1371\/journal.pgen.1008352","article-title":"Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout","volume":"15","author":"Gigu\u00e8re","year":"2019","journal-title":"PLoS Genet"},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0530","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s40263-023-01042-3","article-title":"Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males","volume":"37","author":"Goettel","year":"2023","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0535","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneur.61.8.1280","article-title":"Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system","volume":"61","author":"Goldman","year":"2004","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0540","first-page":"363","article-title":"Bile inhibits release of cholecystokinin and neurotensin","volume":"100","author":"Gomez","year":"1986","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0545","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0016-5085(88)90564-1","article-title":"Regulation of the release of cholecystokinin by bile salts in dogs and humans","volume":"94","author":"Gomez","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yfrne.2024.101122_b0550","doi-asserted-by":"crossref","unstructured":"Gorelick, F. S., & Thrower, E. (2009). The acinar cell and early pancreatitis responses. Clin Gastroenterol Hepatol, 7(11 Suppl), S10-14. doi:10.1016\/j.cgh.2009.07.036.","DOI":"10.1016\/j.cgh.2009.07.036"},{"key":"10.1016\/j.yfrne.2024.101122_b0555","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbr.2015.01.028","article-title":"Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice","volume":"283","author":"Gou","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.yfrne.2024.101122_b0560","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuro.2020.09.001","article-title":"Cholecystokinin-8 attenuates methamphetamine-induced inflammatory activation of microglial cells through CCK2 receptor","volume":"81","author":"Gou","year":"2020","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0565","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/j.1552-4604.1996.tb04204.x","article-title":"Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonist","volume":"36","author":"Grasing","year":"1996","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b0570","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/elps.200800589","article-title":"A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease","volume":"30","author":"Greenberg","year":"2009","journal-title":"Electrophoresis"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0575","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0047-6374(91)90010-W","article-title":"Is Aging Preprogrammed - Observations from the Brain Gut Axis","volume":"61","author":"Greenstein","year":"1991","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0580","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cne.902030303","article-title":"Cholecystokinin in hippocampal pathways","volume":"203","author":"Greenwood","year":"1981","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0585","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/syn.890210209","article-title":"CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat","volume":"21","author":"Gronier","year":"1995","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0590","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2003.12.009","article-title":"Anti-inflammatory effect of acute stress on experimental colitis is mediated by cholecystokinin-B receptors","volume":"75","author":"Gulpinar","year":"2004","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0595","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.mp.4000705","article-title":"Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter","volume":"5","author":"Hansen","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.yfrne.2024.101122_b0600","doi-asserted-by":"crossref","unstructured":"Hao, L., Shi, M., Ma, J., Shao, S., Yuan, Y., Liu, J., Yu, Z., Zhang, Z., H\u00f6lscher, C., & Zhang, Z. (2023). A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK\/Drp1 Pathway in APP\/PS1 Mice [in press]. J Prev Alz Dis. Available at https:\/\/www.researchgate.net\/publication\/375073338_A_Cholecystokinin_analogue_ameliorates_cognitive_deficits_and_regulates_mitochondrial_dynamics_via_the_AMPKDrp1_pathway_in_APPPS1_mice.","DOI":"10.14283\/jpad.2024.6"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0605","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0278-5846(92)90088-V","article-title":"Age-related differences of cholecystokinin receptor binding in the rat brain","volume":"16","author":"Harro","year":"1992","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0610","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0091-3057(93)90160-U","article-title":"Cholecystokinin receptors and memory: a radial maze study","volume":"44","author":"Harro","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0615","first-page":"e9853","article-title":"Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications","volume":"12","author":"Hassan","year":"2020","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b0620","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ajmg.10043","article-title":"Association studies of the CT repeat polymorphism in the 5' upstream region of the cholecystokinin B receptor gene with panic disorder and schizophrenia in Japanese subjects","volume":"105","author":"Hattori","year":"2001","journal-title":"Am. J. Med. Genet."},{"issue":"13","key":"10.1016\/j.yfrne.2024.101122_b0625","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1523\/JNEUROSCI.2035-22.2023","article-title":"A Novel CCK Receptor GPR173 Mediates Potentiation of GABAergic Inhibition","volume":"43","author":"He","year":"2023","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0635","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0091-3057(94)90214-3","article-title":"Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion","volume":"48","author":"Higgins","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b0640","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.07-09-02967.1987","article-title":"Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists","volume":"7","author":"Hill","year":"1987","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0645","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1523\/JNEUROSCI.10-04-01070.1990","article-title":"Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329","volume":"10","author":"Hill","year":"1990","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b0650","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/cercor\/bht101","article-title":"Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study","volume":"24","author":"Hokama","year":"2014","journal-title":"Cereb. Cortex"},{"issue":"5765","key":"10.1016\/j.yfrne.2024.101122_b0655","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/285476a0","article-title":"Evidence for coexistence of dopamine and CCK in meso-limbic neurones","volume":"285","author":"Hokfelt","year":"1980","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0660","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1096-9861(19980302)392:1<48::AID-CNE4>3.0.CO;2-P","article-title":"Peripubertal ontogeny and estrogen stimulation of cholecystokinin and preproenkephalin mRNA in the rat hypothalamus and limbic system","volume":"392","author":"Holland","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.yfrne.2024.101122_b0665","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnagi.2019.00088","article-title":"Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease","volume":"11","author":"Holscher","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0670","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13543784.2020.1738383","article-title":"Brain insulin resistance: role in neurodegenerative disease and potential for targeting","volume":"29","author":"Holscher","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"issue":"18","key":"10.1016\/j.yfrne.2024.101122_b0675","doi-asserted-by":"crossref","first-page":"15850","DOI":"10.1074\/jbc.M212816200","article-title":"The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake","volume":"278","author":"Holtje","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0680","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1523\/JNEUROSCI.05-06-01387.1985","article-title":"Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components","volume":"5","author":"Hommer","year":"1985","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yfrne.2024.101122_b0685","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1749-6632.1985.tb29947.x","article-title":"The effects of cholecystokinin-like peptides in schizophrenics and normal human subjects","volume":"448","author":"Hommer","year":"1985","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0690","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/mcne.1993.1018","article-title":"Differential Gene Expression of CCK(A) and CCK(B) Receptors in the Rat Brain","volume":"4","author":"Honda","year":"1993","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.yfrne.2024.101122_b0695","first-page":"147","article-title":"Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder","volume":"Suppl(68)","author":"Hosing","year":"2004","journal-title":"J Neural Transm"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0700","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00314304","article-title":"Glucose-Metabolism as the Site of the Primary Abnormality in Early-Onset Dementia of Alzheimer Type","volume":"235","author":"Hoyer","year":"1988","journal-title":"J. Neurol."},{"key":"10.1016\/j.yfrne.2024.101122_b0705","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.freeradbiomed.2019.07.001","article-title":"Ghrelin attenuates oxidative stress and neuronal apoptosis via GHSR-1alpha\/AMPK\/Sirt1\/PGC-1alpha\/UCP2 pathway in a rat model of neonatal HIE","volume":"141","author":"Huang","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0710","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0196-9781(89)90114-9","article-title":"Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors","volume":"10","author":"Huang","year":"1989","journal-title":"Peptides"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0715","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(92)90264-A","article-title":"Amphetamine regulation of mesolimbic dopamine\/cholecystokinin neurotransmission","volume":"578","author":"Hurd","year":"1992","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0720","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.npep.2013.04.002","article-title":"Cholecystokinin-8 induces brain-derived neurotrophic factor expression in noradrenergic neuronal cells","volume":"47","author":"Hwang","year":"2013","journal-title":"Neuropeptides"},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b0725","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/dom.12079","article-title":"Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice","volume":"15","author":"Irwin","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"24","key":"10.1016\/j.yfrne.2024.101122_b0730","doi-asserted-by":"crossref","first-page":"18300","DOI":"10.1016\/S0021-9258(17)46844-X","article-title":"Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin","volume":"268","author":"Ito","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0735","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0047-6374(80)90120-7","article-title":"Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases","volume":"14","author":"Iwangoff","year":"1980","journal-title":"Mech. Ageing Dev."},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b0740","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood.V88.7.2683.bloodjournal8872683","article-title":"Autocrine loop through cholecystokinin-B\/gastrin receptors involved in growth of human leukemia cells","volume":"88","author":"Iwata","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0745","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-8993(87)90288-5","article-title":"The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice","volume":"415","author":"Jaffe","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.yfrne.2024.101122_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113795","article-title":"Neurotoxicity of methamphetamine: Main effects and mechanisms","volume":"344","author":"Jayanthi","year":"2021","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0755","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00226-4","article-title":"A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced","volume":"93","author":"Johnstone","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.yfrne.2024.101122_b0760","article-title":"The Signaling and Pharmacology of the Dopamine D1 Receptor","volume":"15","author":"Jones-Tabah","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0765","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7570\/jomes22058","article-title":"Recent Updates on Associations among Various Obesity Metrics and Cognitive Impairment: from Body Mass Index to Sarcopenic Obesity","volume":"31","author":"Jung","year":"2022","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0770","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2007.06.023","article-title":"Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others","volume":"54","author":"Karson","year":"2008","journal-title":"Neuropharmacology"},{"issue":"Suppl","key":"10.1016\/j.yfrne.2024.101122_b0775","article-title":"OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain","volume":"24","author":"Kawano","year":"1994","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0780","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002130050371","article-title":"Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder","volume":"133","author":"Kellner","year":"1997","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b0785","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.psyneuen.2004.01.009","article-title":"Effects of propranolol on symptom and endocrine responses to pentagastrin","volume":"29","author":"Khan","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0790","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5009\/gnl.2008.2.2.74","article-title":"Cerulein pancreatitis: oxidative stress, inflammation, and apoptosis","volume":"2","author":"Kim","year":"2008","journal-title":"Gut Liver"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0795","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1096\/fj.06-5865com","article-title":"A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation","volume":"21","author":"Kim","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.yfrne.2024.101122_b0800","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b0805","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jamda.2019.11.019","article-title":"Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's Disease","volume":"21","author":"Kim","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"14","key":"10.1016\/j.yfrne.2024.101122_b0810","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1523\/JNEUROSCI.4346-04.2005","article-title":"Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia","volume":"25","author":"Kim","year":"2005","journal-title":"J. Neurosci."},{"issue":"663","key":"10.1016\/j.yfrne.2024.101122_b0815","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax7119","article-title":"Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal death","volume":"13","author":"Kim","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.yfrne.2024.101122_b0820","article-title":"The Gut-Brain Axis and Its Relation to Parkinson's Disease: A Review","volume":"13","author":"Klann","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0825","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2010.02.003","article-title":"Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease","volume":"33","author":"Knight","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0830","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/YPG.0b013e32833511a8","article-title":"Gene variations in the cholecystokinin system in patients with panic disorder","volume":"20","author":"Koefoed","year":"2010","journal-title":"Psychiatr. Genet."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0835","first-page":"33","article-title":"Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations","volume":"25","author":"Koks","year":"2000","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0840","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/00365528909093053","article-title":"Do Bile-Acids Exert a Negative Feedback-Control of Cholecystokinin Release","volume":"24","author":"Koop","year":"1989","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0845","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI4901","article-title":"The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight","volume":"103","author":"Kopin","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress Anxiety"},{"issue":"2\u20133","key":"10.1016\/j.yfrne.2024.101122_b0855","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(03)00110-1","article-title":"Sensitivity to cholecystokinin-tetrapeptide in major depression","volume":"80","author":"Koszycki","year":"2004","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b0860","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nn.2804","article-title":"Mechanism of Ca2+\/calmodulin-dependent kinase II regulation of AMPA receptor gating","volume":"14","author":"Kristensen","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0865","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cne.902760206","article-title":"Regional distribution of cholecystokinin receptors in macaque medial temporal lobe determined by in vitro receptor autoradiography","volume":"276","author":"Kritzer","year":"1988","journal-title":"J Comp Neurol"},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0870","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1210\/en.2013-1286","article-title":"beta-Arrestin 2 is a mediator of GnRH-(1\u20135) signaling in immortalized GnRH neurons","volume":"154","author":"Larco","year":"2013","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b0875","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","article-title":"The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms","volume":"44","author":"Le Melledo","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0880","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1073\/pnas.87.1.230","article-title":"Dopamine receptor gene expression by enkephalin neurons in rat forebrain","volume":"87","author":"Le Moine","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.yfrne.2024.101122_b0885","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1016\/S0021-9258(18)53076-3","article-title":"The human brain cholecystokinin-B\/gastrin receptor. Cloning and characterization","volume":"268","author":"Lee","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.yfrne.2024.101122_b0890","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.1970-11.2011","article-title":"Cell-type-specific CCK2 receptor signaling underlies the cholecystokinin-mediated selective excitation of hippocampal parvalbumin-positive fast-spiking basket cells","volume":"31","author":"Lee","year":"2011","journal-title":"J. Neurosci."},{"issue":"Pt 4","key":"10.1016\/j.yfrne.2024.101122_b0895","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1113\/jphysiol.2010.198499","article-title":"Requirement for CB1 but not GABAB receptors in the cholecystokinin mediated inhibition of GABA release from cholecystokinin expressing basket cells","volume":"589","author":"Lee","year":"2011","journal-title":"J Physiol"},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0900","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0905","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1101\/lm.1.3.153","article-title":"CCK-A and CCK-B receptors enhance olfactory recognition via distinct neuronal pathways","volume":"1","author":"Lemaire","year":"1994","journal-title":"Learn Mem"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0910","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF02245565","article-title":"CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats","volume":"115","author":"Lemaire","year":"1994","journal-title":"Psychopharmacology"},{"issue":"7122","key":"10.1016\/j.yfrne.2024.101122_b0915","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b0920","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0031-9384(01)00627-8","article-title":"Spatial memory deficit and emotional abnormality in OLETF rats","volume":"75","author":"Li","year":"2002","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0925","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.kjms.2017.11.002","article-title":"Brain-derived neurotrophic factor preserves intestinal mucosal barrier function and alters gut microbiota in mice","volume":"34","author":"Li","year":"2018","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.yfrne.2024.101122_b0930","first-page":"85","article-title":"AMPK and Autophagy","volume":"1206","author":"Li","year":"2019","journal-title":"Issues in Clinical Epileptology: A View from the Bench"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0935","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/cr.2013.164","article-title":"Cholecystokinin from the entorhinal cortex enables neural plasticity in the auditory cortex","volume":"24","author":"Li","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.yfrne.2024.101122_b0940","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.956500","article-title":"Regulation and physiological functions of phoenixin","volume":"9","author":"Liang","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"59","key":"10.1016\/j.yfrne.2024.101122_b0945","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.physiol.59.1.221","article-title":"Cholecystokinin cells","volume":"79","author":"Liddle","year":"1997","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0950","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MCO.0000000000000759","article-title":"Ketogenic diet therapy in Alzheimer's disease: an updated review","volume":"24","author":"Lilamand","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b0955","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/glia.22502","article-title":"Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB","volume":"61","author":"Lim","year":"2013","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b0960","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/1533317513506774","article-title":"Related genes and potential biomarkers for early diagnosis of Alzheimer's disease: a preliminary study based on DNA microarray","volume":"29","author":"Lin","year":"2014","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b0965","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/s41401-023-01104-8","article-title":"Loss of DJ-1 function contributes to Parkinson's disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation","volume":"44","author":"Liu","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yfrne.2024.101122_b0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111212","article-title":"Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease","volume":"186","author":"Liu","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b0975","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.1080\/21655979.2021.1999549","article-title":"Identification of hub genes associated with cognition in the hippocampus of Alzheimer's Disease","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b0980","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41589-021-00841-3","article-title":"Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor","volume":"17","author":"Liu","year":"2021","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b0985","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00682.2007","article-title":"Characterization of mice lacking the gene for cholecystokinin","volume":"294","author":"Lo","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b0990","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF01273363","article-title":"Cholecystokinin peptides and receptor binding in Alzheimer's disease","volume":"103","author":"Lofberg","year":"1996","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b0995","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)65221-2","article-title":"Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions","volume":"155","author":"Lommatzsch","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yfrne.2024.101122_b1000","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.963933","article-title":"Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis","volume":"14","author":"Long","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12017-012-8199-5","article-title":"The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer's disease","volume":"15","author":"Long-Smith","year":"2013","journal-title":"Neuromolecular Med"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(02)03222-5","article-title":"Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats","volume":"952","author":"Lorigados Pedre","year":"2002","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00429-002-0237-x","article-title":"Localisation of neurotrophin - containing cells in higher vertebrate intestine","volume":"205","author":"Lucini","year":"2002","journal-title":"Anat Embryol (Berl)"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajpath.2015.09.023","article-title":"Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly","volume":"186","author":"Luo","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yfrne.2024.101122_b1025","doi-asserted-by":"crossref","unstructured":"Luyer, M. D., Greve, J. W., Hadfoune, M., Jacobs, J. A., Dejong, C. H., & Buurman, W. A. (2005). Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med, 202(8), 1023-1029. doi:10.1084\/jem.20042397.","DOI":"10.1084\/jem.20042397"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b1030","doi-asserted-by":"crossref","first-page":"e2231","DOI":"10.1002\/brb3.2231","article-title":"The GLP-1\/GIP dual-receptor agonist DA5-CH inhibits the NF-kappaB inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP-1 single-receptor agonist NLY01","volume":"11","author":"Lv","year":"2021","journal-title":"Brain Behav"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0404.1981.tb00788.x","article-title":"Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids","volume":"63","author":"Lying-Tunell","year":"1981","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.yfrne.2024.101122_b1040","doi-asserted-by":"crossref","first-page":"100024","DOI":"10.1016\/j.addicn.2022.100024","article-title":"Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction","volume":"3","author":"Ma","year":"2022","journal-title":"Addict Neurosci"},{"issue":"28","key":"10.1016\/j.yfrne.2024.101122_b1045","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.yfrne.2024.101122_b1050","doi-asserted-by":"crossref","first-page":"9204","DOI":"10.1523\/JNEUROSCI.21-23-09204.2001","article-title":"Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo","volume":"21","author":"Mabuchi","year":"2001","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/phrs.2000.0692","article-title":"Reciprocal effect of unsulfated and sulfated forms of cholecystokinin-octapeptide on gastric acid secretion in the rat","volume":"42","author":"Maeda","year":"2000","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","article-title":"Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome","volume":"15","author":"MahmoudianDehkordi","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-017-1297-5","article-title":"Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer's disease","volume":"14","author":"Marksteiner","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.yfrne.2024.101122_b1070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/bs.ircmb.2014.10.002","article-title":"Biogenesis and function of the NGF\/TrkA signaling endosome","volume":"314","author":"Marlin","year":"2015","journal-title":"Int Rev Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1075","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-4159.1991.tb02009.x","article-title":"Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms","volume":"56","author":"Marshall","year":"1991","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1080","doi-asserted-by":"crossref","first-page":"e34236","DOI":"10.1371\/journal.pone.0034236","article-title":"Methamphetamine causes differential alterations in gene expression and patterns of histone acetylation\/hypoacetylation in the rat nucleus accumbens","volume":"7","author":"Martin","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2022.06.011","article-title":"Somatodendritic Release of Cholecystokinin Potentiates GABAergic Synapses Onto Ventral Tegmental Area Dopamine Cells","volume":"93","author":"Martinez Damonte","year":"2023","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yfrne.2024.101122_b1090","doi-asserted-by":"crossref","DOI":"10.1177\/1533317520953041","article-title":"The Dual GLP-1\/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP\/PS1 Mouse Model of Alzheimer's Disease","volume":"35","author":"Maskery","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0143-4179(03)00083-0","article-title":"Spatial memory impairment in OLETF rats without cholecystokinin - a receptor","volume":"37","author":"Matsushita","year":"2003","journal-title":"Neuropeptides"},{"key":"10.1016\/j.yfrne.2024.101122_b1100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.physbeh.2016.08.025","article-title":"CCK increases the transport of insulin into the brain","volume":"165","author":"May","year":"2016","journal-title":"Physiol Behav"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1105","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/WNL.41.5.716","article-title":"Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex","volume":"41","author":"Mazurek","year":"1991","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0893-133X(96)00197-2","article-title":"A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls","volume":"16","author":"McCann","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"26","key":"10.1016\/j.yfrne.2024.101122_b1115","doi-asserted-by":"crossref","first-page":"17681","DOI":"10.1074\/jbc.M600207200","article-title":"CAAT\/enhancer-binding protein delta and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system","volume":"281","author":"McCauslin","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1120","doi-asserted-by":"crossref","first-page":"bvab192","DOI":"10.1210\/jendso\/bvab192","article-title":"The Regulation of Phoenixin: A Fascinating Multidimensional Peptide","volume":"6","author":"McIlwraith","year":"2022","journal-title":"J Endocr Soc"},{"issue":"6523","key":"10.1016\/j.yfrne.2024.101122_b1125","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/374647a0","article-title":"Activation of microglial cells by beta-amyloid protein and interferon-gamma","volume":"374","author":"Meda","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/ADR-210294","article-title":"The Relationship Between Anxiety and Alzheimer's Disease","volume":"5","author":"Mendez","year":"2021","journal-title":"Journal of Alzheimers Disease Reports"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1135","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3748\/wjg.v8.i4.712","article-title":"Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat","volume":"8","author":"Meng","year":"2002","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1140","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.4081\/ni.2014.5388","article-title":"Highly Expressed Genes within Hippocampal Sector CA1: Implications for the Physiology of Memory","volume":"6","author":"Meyer","year":"2014","journal-title":"Neurol Int"},{"issue":"5898","key":"10.1016\/j.yfrne.2024.101122_b1145","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/301338a0","article-title":"Dopamine modulates cholecystokinin release in neostriatum","volume":"301","author":"Meyer","year":"1983","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b1150","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0196-9781(01)00447-8","article-title":"Estrogen and endogenous opioids regulate CCK in reproductive circuits","volume":"22","author":"Micevych","year":"2001","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1155","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0028-3908(94)90113-9","article-title":"Effects of cholecystokinin octapeptide and BC 264, a potent and selective CCK-B agonist on aspartate and glutamate release from rat hippocampal slices","volume":"33","author":"Migaud","year":"1994","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b1160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tem.2016.04.002","article-title":"Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target","volume":"27","author":"Miller","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.yfrne.2024.101122_b1165","article-title":"Roles of Cholecystokinin in the Nutritional Continuum","volume":"12","author":"Miller","year":"2021","journal-title":"Physiology and Potential Therapeutics. Front Endocrinol (Lausanne)"},{"issue":"13","key":"10.1016\/j.yfrne.2024.101122_b1170","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1523\/JNEUROSCI.17-13-04994.1997","article-title":"Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons","volume":"17","author":"Miller","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yfrne.2024.101122_b1175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnins.2019.00038","article-title":"Innovative Therapy for Alzheimer's Disease-With Focus on Biodelivery of NGF","volume":"13","author":"Mitra","year":"2019","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1180","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2337\/db11-0402","article-title":"Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin","volume":"61","author":"Miyamoto","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0167-4943(95)00635-X","article-title":"Sex difference in gene expressions of cholecystokinin (CCK) and CCK receptor in young and old rats","volume":"21","author":"Miyasaka","year":"1995","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1190","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b1195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(97)00865-2","article-title":"Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus\/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat","volume":"770","author":"Monnikes","year":"1997","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1200","article-title":"Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid","volume":"273","author":"Monnikes","year":"1997","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1205","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1471-4159.2003.02265.x","article-title":"A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization","volume":"87","author":"Moore","year":"2003","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1210","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells","volume":"37","author":"Morales","year":"2013","journal-title":"Journal of Alzheimers Disease"},{"key":"10.1016\/j.yfrne.2024.101122_b1215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(86)91413-7","article-title":"Two brain cholecystokinin receptors: implications for behavioral actions","volume":"362","author":"Moran","year":"1986","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1225","article-title":"Disordered food intake and obesity in rats lacking cholecystokinin A receptors","volume":"274","author":"Moran","year":"1998","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0306-4522(96)00675-6","article-title":"Characterization of cholecystokininA and cholecystokininB receptors expressed by vagal afferent neurons","volume":"79","author":"Moriarty","year":"1997","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1460-9568.1994.tb00980.x","article-title":"Cholecystokinin in cortico-striatal neurons in the rat: immunohistochemical studies at the light and electron microscopical level","volume":"6","author":"Morino","year":"1994","journal-title":"Eur J Neurosci"},{"issue":"11","key":"10.1016\/j.yfrne.2024.101122_b1240","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1177\/002215540305101110","article-title":"Localization of cholecystokinin receptor subtypes in the endocine pancreas","volume":"51","author":"Morisset","year":"2003","journal-title":"J. Histochem. Cytochem."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00313602","article-title":"Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease","volume":"87","author":"Moroo","year":"1994","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.ijo.0803716","article-title":"Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet","volume":"32","author":"Morris","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.yfrne.2024.101122_b1255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2014.04.006","article-title":"Insulin resistance and gray matter volume in neurodegenerative disease","volume":"270","author":"Morris","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.yfrne.2024.101122_b1260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yfrne.2024.101122_b1265","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00213","article-title":"Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?","volume":"14","author":"Muddapu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1270","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1152\/jn.1997.78.4.1997","article-title":"Cholecystokinin activates CCKB-receptor-mediated Ca-signaling in hippocampal astrocytes","volume":"78","author":"Muller","year":"1997","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0893-133X(00)00099-3","article-title":"Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain","volume":"23","author":"Muller","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yfrne.2024.101122_b1280","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","article-title":"Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages","volume":"9","author":"Neth","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.yfrne.2024.101122_b1285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.2006.115691","article-title":"Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus","volume":"578","author":"Neu","year":"2007","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1290","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","article-title":"Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers","volume":"15","author":"Nho","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1295","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1074\/mcp.M800454-MCP200","article-title":"Striatal alterations of secretogranin-1, somatostatin, prodynorphin, and cholecystokinin peptides in an experimental mouse model of Parkinson disease","volume":"8","author":"Nilsson","year":"2009","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1300","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0031-9384(99)00033-5","article-title":"Impaired learning and memory in OLETF rats without cholecystokinin (CCK)-A receptor","volume":"66","author":"Nomoto","year":"1999","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1305","doi-asserted-by":"crossref","first-page":"e0214364","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1310","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cne.902370406","article-title":"Cholecystokinin-immunoreactive cells form symmetrical synaptic contacts with pyramidal and nonpyramidal neurons in the hippocampus","volume":"237","author":"Nunzi","year":"1985","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1315","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euroneuro.2017.12.004","article-title":"The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus","volume":"28","author":"O\u2019Leary","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1320","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/febs.13976","article-title":"A whole animal chemical screen approach to identify modifiers of intestinal neutrophilic inflammation","volume":"284","author":"Oehlers","year":"2017","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1325","first-page":"27","article-title":"Altered energy metabolism in Alzheimer's disease","volume":"34","author":"Ogawa","year":"1994","journal-title":"Rinsho Shinkeigaku"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1330","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease","volume":"45","author":"Olazaran","year":"2015","journal-title":"Journal of Alzheimers Disease"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1335","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3233\/JAD-121990","article-title":"Slow excitotoxicity in Alzheimer's disease","volume":"35","author":"Ong","year":"2013","journal-title":"Journal of Alzheimers Disease"},{"key":"10.1016\/j.yfrne.2024.101122_b1340","series-title":"Current Thoughts on Dementia","article-title":"Gut-Brain Axis in Alzheimer\u2019s Disease: Interplay Between Cholecystokinin, Dysbiosis, and Brain-Derived Neurotrophic Factor","author":"Ouerdane","year":"2022"},{"issue":"18","key":"10.1016\/j.yfrne.2024.101122_b1350","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020860","article-title":"Liraglutide Has Anti-Inflammatory and Anti-Amyloid Properties in Streptozotocin-Induced and 5xFAD Mouse Models of Alzheimer's Disease","volume":"22","author":"Paladugu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031170","article-title":"BDNF as a Promising Therapeutic Agent in Parkinson's Disease","volume":"21","author":"Palasz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b1365","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1370","doi-asserted-by":"crossref","DOI":"10.3390\/metabo7020028","article-title":"Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's Disease","volume":"7","author":"Pan","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.yfrne.2024.101122_b1375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fpsyg.2015.00027","article-title":"Ketosis, ketogenic diet and food intake control: a complex relationship","volume":"6","author":"Paoli","year":"2015","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1380","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41531-022-00353-4","article-title":"Waist circumference and risk of Parkinson's disease","volume":"8","author":"Park","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.yfrne.2024.101122_b1385","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.peptides.2017.09.007","article-title":"Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes","volume":"100","author":"Pathak","year":"2018","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1390","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1007\/s12035-016-9944-9","article-title":"The Interaction of Mitochondrial Biogenesis and Fission\/Fusion Mediated by PGC-1alpha Regulates Rotenone-Induced Dopaminergic Neurotoxicity","volume":"54","author":"Peng","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b1395","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1038\/s41380-020-0797-2","article-title":"The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease","volume":"26","author":"Pentz","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b1400","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1460-9568.2007.05963.x","article-title":"Role of the amygdaloid cholecystokinin (CCK)\/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release","volume":"26","author":"P\u00e9rez de la Mora","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1405","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(81)90123-4","article-title":"Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex","volume":"51","author":"Perry","year":"1981","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1410","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.physbeh.2006.06.017","article-title":"Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin","volume":"89","author":"Peters","year":"2006","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1415","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0166-4328(93)90118-A","article-title":"Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement","volume":"55","author":"Phillips","year":"1993","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0167-8760(94)90058-2","article-title":"Comparison of satiating effects of ceruletide and food intake using behavioral and electrophysiological indicators of memory","volume":"17","author":"Pietrowsky","year":"1994","journal-title":"Int J Psychophysiol"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1425","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0306-4530(96)00012-1","article-title":"A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin","volume":"21","author":"Pietrowsky","year":"1996","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1430","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000054899","article-title":"Time course of intranasally administered cholecystokinin-8 on central nervous effects","volume":"43","author":"Pietrowsky","year":"2001","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.yfrne.2024.101122_b1435","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2019.01.002","article-title":"Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance","volume":"76","author":"Plagman","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.yfrne.2024.101122_b1440","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2015.00199","article-title":"Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients","volume":"9","author":"Prinz","year":"2015","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1445","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer's disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.yfrne.2024.101122_b1450","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neures.2021.01.001","article-title":"Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications","volume":"168","author":"Rani","year":"2021","journal-title":"Neurosci. Res."},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b1455","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41583-018-0041-0","article-title":"Enteric nervous system development: what could possibly go wrong?","volume":"19","author":"Rao","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1460","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-005-2255-x","article-title":"Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test","volume":"181","author":"Raud","year":"2005","journal-title":"Psychopharmacology"},{"issue":"38","key":"10.1016\/j.yfrne.2024.101122_b1465","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and toll-like receptors 2 and 4 are required for fibrillar Abeta-stimulated microglial activation","volume":"29","author":"Reed-Geaghan","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1470","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.yfrne.2024.101122_b1475","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/S0021-9258(17)34793-2","article-title":"Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog","volume":"253","author":"Rehfeld","year":"1978","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1480","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/clinchem\/44.5.991","article-title":"Accurate measurement of cholecystokinin in plasma","volume":"44","author":"Rehfeld","year":"1998","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1485","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1748-1716.2010.02235.x","article-title":"Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides","volume":"201","author":"Rehfeld","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.yfrne.2024.101122_b1490","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fendo.2017.00047","article-title":"Cholecystokinin-From Local Gut Hormone to Ubiquitous Messenger","volume":"8","author":"Rehfeld","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.yfrne.2024.101122_b1495","doi-asserted-by":"crossref","DOI":"10.1177\/1179551419883608","article-title":"Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy","volume":"12","author":"Rehfeld","year":"2019","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"18","key":"10.1016\/j.yfrne.2024.101122_b1500","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26185657","article-title":"Cholecystokinin and Panic Disorder: Reflections on the History and Some Unsolved Questions","volume":"26","author":"Rehfeld","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1505","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0006-8993(92)90615-G","article-title":"Expression, but failing maturation of procholecystokinin in cerebellum","volume":"576","author":"Rehfeld","year":"1992","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1510","first-page":"251","article-title":"The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33","volume":"86","author":"Rehfeld","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1515","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/en.2007-0278","article-title":"The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1\/3, 2, and 5\/6","volume":"149","author":"Rehfeld","year":"2008","journal-title":"Endocrinology"},{"issue":"13","key":"10.1016\/j.yfrne.2024.101122_b1520","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1016\/S0021-9258(17)38458-2","article-title":"Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways","volume":"261","author":"Rehfeld","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yfrne.2024.101122_b1525","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.614828","article-title":"Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease","volume":"14","author":"Reich","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yfrne.2024.101122_b1530","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104952","article-title":"Beyond appetite: Acylated ghrelin as a learning, memory and fear behavior-modulating hormone","volume":"143","author":"Reich","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yfrne.2024.101122_b1535","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.970925","article-title":"The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review","volume":"16","author":"Reich","year":"2022","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/brain.2020.0879","article-title":"Understanding Changes in Hippocampal Interneurons Subtypes in the Pathogenesis of Alzheimer's Disease: A Systematic Review","volume":"11","author":"Reid","year":"2021","journal-title":"Brain Connect"},{"key":"10.1016\/j.yfrne.2024.101122_b1545","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/2277-9175.166650","article-title":"Effect of cholecystokinin on learning and memory, neuronal proliferation and apoptosis in the rat hippocampus","volume":"4","author":"Reisi","year":"2015","journal-title":"Adv Biomed Res"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1550","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002100100454","article-title":"Localization and characterization of neuropeptide receptors in human colon","volume":"364","author":"Rettenbacher","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1555","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0016-5085(97)70131-8","article-title":"Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach","volume":"112","author":"Reubi","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1560","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<376::AID-IJC11>3.0.CO;2-5","article-title":"Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located?","volume":"81","author":"Reubi","year":"1999","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b1565","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(94)90681-5","article-title":"Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety","volume":"172","author":"Rex","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1570","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF01181525","article-title":"Five types of basket cell in the hippocampal dentate gyrus: a combined Golgi and electron microscopic study","volume":"12","author":"Ribak","year":"1983","journal-title":"J Neurocytol"},{"issue":"1672","key":"10.1016\/j.yfrne.2024.101122_b1575","doi-asserted-by":"crossref","first-page":"20140185","DOI":"10.1098\/rstb.2014.0185","article-title":"Somatodendritic dopamine release: recent mechanistic insights","volume":"370","author":"Rice","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.yfrne.2024.101122_b1580","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/2277-9175.161577","article-title":"Effects of repeated treatment with cholecystokinin sulfated octapeptide on passive avoidance memory under chronic restraint stress in male rats","volume":"4","author":"Sadeghi","year":"2015","journal-title":"Adv Biomed Res"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1585","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SHK.0000000000001355","article-title":"Cholecystokinin Modulates the Mucosal Inflammatory Response and Prevents the Lipopolysaccharide-Induced Intestinal Epithelial Barrier Dysfunction","volume":"53","author":"Saia","year":"2020","journal-title":"Shock"},{"key":"10.1016\/j.yfrne.2024.101122_b1590","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107813","article-title":"Neuroprotective and restorative properties of the GLP-1\/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease","volume":"162","author":"Salles","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yfrne.2024.101122_b1595","first-page":"465","article-title":"Glucagon and CCK in human brain: controls and patients with senile dementia of Alzheimer type","volume":"55","author":"Sanders","year":"1982","journal-title":"Essence of Memory"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1600","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b1610","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.yfrne.2024.101122_b1615","doi-asserted-by":"crossref","unstructured":"Scheperjans, F., Derkinderen, P., & Borghammer, P. (2018). The Gut and Parkinson's Disease: Hype or Hope? J Parkinsons Dis, 8(s1), S31-S39. doi:10.3233\/JPD-181477.","DOI":"10.3233\/JPD-181477"},{"issue":"2\u20133","key":"10.1016\/j.yfrne.2024.101122_b1620","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-0115(01)00307-X","article-title":"Cellular expression of CCK-A and CCK-B\/gastrin receptors in human gastric mucosa","volume":"102","author":"Schmitz","year":"2001","journal-title":"Regul Pept"},{"issue":"1\u20133","key":"10.1016\/j.yfrne.2024.101122_b1625","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(01)00281-6","article-title":"Identification of CCK-B\/gastrin receptor splice variants in human peripheral blood mononuclear cells","volume":"101","author":"Schmitz","year":"2001","journal-title":"Regul Pept"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1630","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biopsycho.2004.08.006","article-title":"Intranasally administered Cholecystokinin decreases controlled memory","volume":"69","author":"Schneider","year":"2005","journal-title":"Biol. Psychol."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1635","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00213-008-1332-3","article-title":"Effect of intranasally administered cholecystokinin on encoding of controlled and automatic memory processes","volume":"202","author":"Schneider","year":"2009","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1640","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.neuroimage.2006.01.035","article-title":"Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety","volume":"31","author":"Schunck","year":"2006","journal-title":"Neuroimage"},{"issue":"16","key":"10.1016\/j.yfrne.2024.101122_b1645","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1523\/JNEUROSCI.19-16-07230.1999","article-title":"Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation","volume":"19","author":"Sebret","year":"1999","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1650","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/psyg.12316","article-title":"Prevalence of hyperphagia in Alzheimer's disease: a meta-analysis","volume":"18","author":"Shea","year":"2018","journal-title":"Psychogeriatrics"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b1655","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1660","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1665","first-page":"332","article-title":"Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder","volume":"22","author":"Shlik","year":"1997","journal-title":"J Psychiatry Neurosci"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1670","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0196-9781(98)00056-4","article-title":"Decrease in short-term memory function induced by CCK-4 in healthy volunteers","volume":"19","author":"Shlik","year":"1998","journal-title":"Peptides"},{"issue":"2\u20133","key":"10.1016\/j.yfrne.2024.101122_b1675","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3940(90)90222-U","article-title":"Effect of dopamine depletion upon the K(+)-evoked release of CCK from superfused striatal slices","volume":"112","author":"Sierralta","year":"1990","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1680","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0028-3908(02)00382-9","article-title":"Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus","volume":"44","author":"Silva","year":"2003","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1685","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1096\/fj.06-6163com","article-title":"Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus","volume":"21","author":"Silva","year":"2007","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"Pt 7","key":"10.1016\/j.yfrne.2024.101122_b1695","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology","volume":"132","author":"Simunovic","year":"2009","journal-title":"Brain"},{"issue":"1\u20133","key":"10.1016\/j.yfrne.2024.101122_b1700","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0304-3940(88)90682-9","article-title":"Cholecystokinin modulates neurotransmission through the dentate gyrus","volume":"95","author":"Sinton","year":"1988","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1705","doi-asserted-by":"crossref","first-page":"G91","DOI":"10.1152\/ajpgi.00301.2013","article-title":"Cholecystokinin and pancreatic cancer: the chicken or the egg?","volume":"306","author":"Smith","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1710","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00213-002-1010-9","article-title":"Brain potential signs of slowed stimulus processing following cholecystokinin in Parkinson's disease","volume":"161","author":"Smolnik","year":"2002","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b1715","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1523\/JNEUROSCI.04-10-02590.1984","article-title":"Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material","volume":"4","author":"Somogyi","year":"1984","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1720","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/db05-0509","article-title":"Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2","volume":"55","author":"Soriano","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1725","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"Journal of Alzheimers Disease"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1730","first-page":"204","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Inflammation in CNS neurodegenerative diseases. Immunology"},{"issue":"5","key":"10.1016\/j.yfrne.2024.101122_b1735","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0016-5085(99)70399-9","article-title":"Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine","volume":"117","author":"Sternini","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1740","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1745","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","article-title":"Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder","volume":"22","author":"Strohle","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1750","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0031-9384(96)83164-7","article-title":"Devazepide increases food intake in male but not female Zucker rats","volume":"60","author":"Strohmayer","year":"1996","journal-title":"Physiol Behav"},{"key":"10.1016\/j.yfrne.2024.101122_b1755","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175029","article-title":"Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and alpha-synuclein accumulation in the colon of two Parkinson's disease mouse models","volume":"926","author":"Su","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b1760","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.2337\/db08-0688","article-title":"Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice","volume":"57","author":"Suarez-Pinzon","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1765","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mds.25187","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson's disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1770","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.baga.2016.02.001","article-title":"Striatal dopamine neurotransmission: regulation of release and uptake","volume":"6","author":"Sulzer","year":"2016","journal-title":"Basal Ganglia"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1775","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1780","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00429-013-0692-6","article-title":"Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus","volume":"220","author":"Takacs","year":"2015","journal-title":"Brain Struct. Funct."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1785","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(96)12357-0","article-title":"Insulin receptor mRNA in the substantia nigra in Parkinson's disease","volume":"204","author":"Takahashi","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1790","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b1795","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(92)91691-7","article-title":"Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity","volume":"592","author":"Tamura","year":"1992","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b1800","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41401-023-01063-0","article-title":"Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model through activating GHS-R1a\/D(2)R heterodimers","volume":"44","author":"Tang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1805","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(92)90295-F","article-title":"Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia","volume":"219","author":"Taylor","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.yfrne.2024.101122_b1810","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1073\/pnas.96.11.6473","article-title":"Cholecystokinin-8 protects central cholinergic neurons against fimbria-fornix lesion through the up-regulation of nerve growth factor synthesis","volume":"96","author":"Tirassa","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1815","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuint.2006.07.008","article-title":"CCK-8 induces NGF and BDNF synthesis and modulates TrkA and TrkB expression in the rat hippocampus and septum: Effects on kindling development","volume":"50","author":"Tirassa","year":"2007","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1820","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/sj.bjp.0701718","article-title":"Cholecystokinin-8 regulation of NGF concentrations in adult mouse brain through a mechanism involving CCK(A) and CCK(B) receptors","volume":"123","author":"Tirassa","year":"1998","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1825","first-page":"155","article-title":"Characterization of cholecystokinin receptors on the human gallbladder","volume":"113","author":"Tokunaga","year":"1993","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1830","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2009-0995","article-title":"Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity","volume":"16","author":"Tong","year":"2009","journal-title":"Journal of Alzheimers Disease"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b1835","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1210\/me.2016-1039","article-title":"Phoenixin Activates Immortalized GnRH and Kisspeptin Neurons Through the Novel Receptor GPR173","volume":"30","author":"Treen","year":"2016","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1840","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/dom.12390","article-title":"Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents","volume":"17","author":"Trevaskis","year":"2015","journal-title":"Diabetes Obes. Metab."},{"issue":"6220","key":"10.1016\/j.yfrne.2024.101122_b1845","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1850","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(81)90420-1","article-title":"Separate populations of cholecystokinin and 5-hydroxytryptamine-containing neuronal cells in the rat dorsal raphe, and their contribution to the ascending raphe projections","volume":"26","author":"van der Kooy","year":"1981","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1855","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1523\/JNEUROSCI.04-04-01021.1984","article-title":"Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand","volume":"4","author":"Van Dijk","year":"1984","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.yfrne.2024.101122_b1860","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050201","article-title":"Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks","volume":"129","author":"van Megen","year":"1997","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1865","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-3223(97)00185-6","article-title":"Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls","volume":"42","author":"van Vliet","year":"1997","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1870","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jnc.12036","article-title":"Neuroprotective actions of glucagon-like peptide-1 in differentiated human neuroprogenitor cells","volume":"123","author":"Velmurugan","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.yfrne.2024.101122_b1875","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neubiorev.2016.11.017","article-title":"Weight loss is associated with improvements in cognitive function among overweight and obese people: A systematic review and meta-analysis","volume":"72","author":"Veronese","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1880","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12934-021-01520-7","article-title":"Multi-pathogen infections and Alzheimer's disease","volume":"20","author":"Vigasova","year":"2021","journal-title":"Microb Cell Fact"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1885","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1037\/0735-7044.122.3.491","article-title":"Altered ingestive behavior, weight changes, and intact olfactory sense in an APP overexpression model","volume":"122","author":"Vloeberghs","year":"2008","journal-title":"Behav. Neurosci."},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b1890","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0196-9781(01)00459-4","article-title":"Repeated treatment with cholecystokinin octapeptide improves maze performance in aged Fischer 344 rats","volume":"22","author":"Voits","year":"2001","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1895","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1523-1755.2000.00257.x","article-title":"CCKB\/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney","volume":"58","author":"von Schrenck","year":"2000","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1900","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008571-200306000-00008","article-title":"Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease","volume":"13","author":"Wang","year":"2003","journal-title":"Pharmacogenetics"},{"issue":"49","key":"10.1016\/j.yfrne.2024.101122_b1905","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","volume":"105","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"28","key":"10.1016\/j.yfrne.2024.101122_b1910","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer's disease","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1915","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S","article-title":"Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder","volume":"81","author":"Wang","year":"1998","journal-title":"Am. J. Med. Genet."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1920","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41531-021-00213-7","article-title":"Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation","volume":"7","author":"Wang","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1925","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","article-title":"Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management","volume":"8","author":"Warnecke","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"2\u20133","key":"10.1016\/j.yfrne.2024.101122_b1935","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.physbeh.2004.04.065","article-title":"The role of CCK2 receptors in energy homeostasis: insights from the CCK2 receptor-deficient mouse","volume":"82","author":"Weiland","year":"2004","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1940","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI119570","article-title":"Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma","volume":"100","author":"Weinberg","year":"1997","journal-title":"J. Clin. Investig."},{"issue":"5 Pt 2","key":"10.1016\/j.yfrne.2024.101122_b1945","article-title":"Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats","volume":"246","author":"West","year":"1984","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1950","article-title":"Selective Activation of Cholecystokinin-Expressing GABA (CCK-GABA)","volume":"6","author":"Whissell","year":"2019","journal-title":"Neurons Enhances Memory and Cognition. Eneuro"},{"key":"10.1016\/j.yfrne.2024.101122_b1955","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/ncomms6540","article-title":"Diacylglycerol mediates regulation of TASK potassium channels by Gq-coupled receptors","volume":"5","author":"Wilke","year":"2014","journal-title":"Nat. Commun."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b1960","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(94)91087-1","article-title":"CCK-8-evoked cationic currents in substantia nigra dopaminergic neurons are mediated by InsP3-induced Ca2+ release","volume":"175","author":"Wu","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.yfrne.2024.101122_b1965","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3940(94)90325-5","article-title":"CCK-8 excites substantia nigra dopaminergic neurons by increasing a cationic conductance","volume":"170","author":"Wu","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.yfrne.2024.101122_b1970","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brainres.2003.10.064","article-title":"Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure","volume":"1001","author":"Wunderlich","year":"2004","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1975","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","article-title":"Roles of bile acids signaling in neuromodulation under physiological and pathological conditions","volume":"13","author":"Xing","year":"2023","journal-title":"Cell Biosci"},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b1980","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10072-017-3157-5","article-title":"Decreased serum proNGF concentration in patients with Parkinson's disease","volume":"39","author":"Xu","year":"2018","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b1985","doi-asserted-by":"crossref","first-page":"426","DOI":"10.14336\/AD.2015.0204","article-title":"Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease","volume":"6","author":"Xu","year":"2015","journal-title":"Aging Dis."},{"issue":"11","key":"10.1016\/j.yfrne.2024.101122_b1990","doi-asserted-by":"crossref","first-page":"e78374","DOI":"10.1371\/journal.pone.0078374","article-title":"Transcriptional activation of the cholecystokinin gene by DJ-1 through interaction of DJ-1 with RREB1 and the effect of DJ-1 on the cholecystokinin level in mice","volume":"8","author":"Yamane","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b1995","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0306-4522(96)00149-2","article-title":"Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity","volume":"74","author":"You","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.yfrne.2024.101122_b2000","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2017.06.029","article-title":"A novel GLP-1\/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease","volume":"812","author":"Yuan","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.yfrne.2024.101122_b2005","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bbamem.2012.10.004","article-title":"Regulation of Ca(V)2 calcium channels by G protein coupled receptors","volume":"1828","author":"Zamponi","year":"2013","journal-title":"BBA"},{"key":"10.1016\/j.yfrne.2024.101122_b2010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fendo.2020.00112","article-title":"Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes","volume":"11","author":"Zeng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.yfrne.2024.101122_b2015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainres.2011.01.065","article-title":"Impairment of synaptic plasticity in hippocampus is exacerbated by methylprednisolone in a rat model of traumatic brain injury","volume":"1382","author":"Zhang","year":"2011","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.yfrne.2024.101122_b2020","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1096\/fj.201801526RR","article-title":"Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.yfrne.2024.101122_b2025","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/s41589-021-00866-8","article-title":"Structures of the human cholecystokinin receptors bound to agonists and antagonists","volume":"17","author":"Zhang","year":"2021","journal-title":"Nat Chem Biol"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b2030","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4103\/1673-5374.389361","article-title":"Glucagon-like peptide-1\/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model","volume":"16","author":"Zhang","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.yfrne.2024.101122_b2035","article-title":"Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson's Disease Mouse Model","volume":"16","author":"Zhang","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yfrne.2024.101122_b2040","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fimmu.2020.00994","article-title":"Role of DJ-1 in Immune and Inflammatory Diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yfrne.2024.101122_b2045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2013.03.023","article-title":"CCK-8S increased the filopodia and spines density in cultured hippocampal neurons of APP\/PS1 and wild-type mice","volume":"542","author":"Zhang","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.yfrne.2024.101122_b2050","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1523\/JNEUROSCI.1673-19.2019","article-title":"Visuoauditory Associative Memory Established with Cholecystokinin Under Anesthesia Is Retrieved in Behavioral Contexts","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b2055","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1007\/s12035-023-03388-7","article-title":"Cholecystokinin Signaling can Rescue Cognition and Synaptic Plasticity in the APP\/PS1 Mouse Model of Alzheimer's Disease","volume":"60","author":"Zhang","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.yfrne.2024.101122_b2060","first-page":"565","article-title":"Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects","volume":"11","author":"Zhao","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"10.1016\/j.yfrne.2024.101122_b2065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jnr.490150310","article-title":"Blood-CSF barrier to CCK and effect of centrally administered bombesin on release of brain CCK","volume":"15","author":"Zhu","year":"1986","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.yfrne.2024.101122_b2070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-201235","article-title":"Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses","volume":"80","author":"Zhuang","year":"2021","journal-title":"Journal of Alzheimers Disease"},{"issue":"8","key":"10.1016\/j.yfrne.2024.101122_b2075","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.numecd.2021.03.020","article-title":"Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis","volume":"31","author":"Zuin","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.yfrne.2024.101122_b2080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/da.21919","article-title":"Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin","volume":"29","author":"Zwanzger","year":"2012","journal-title":"Depress Anxiety"},{"issue":"Suppl 1","key":"10.1016\/j.yfrne.2024.101122_b2085","first-page":"13","article-title":"Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome","volume":"58","author":"Zwirska-Korczala","year":"2007","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Frontiers in Neuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302224000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091302224000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T20:15:08Z","timestamp":1728591308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091302224000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":413,"alternative-id":["S0091302224000025"],"URL":"https:\/\/doi.org\/10.1016\/j.yfrne.2024.101122","relation":{},"ISSN":["0091-3022"],"issn-type":[{"value":"0091-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer\u2019s and Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Frontiers in Neuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yfrne.2024.101122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101122"}}